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Abstract  
Introduction: The association of neuroblastoma and congenital heart disease might have clinical consequences and 
cardiac screening might be required for all patients diagnosed with neuroblastoma for further management. 
Presentation of case: We report a case of a neonate, who presented to the paediatrics assessment unit with severe 
abdominal distension, on examination massive hepatomegaly and spleenomegaly were noted and a heart murmur was 
detected. He was admitted to the paediatric department and the laboratory results showed high levels of urinary 
catecholamines and their metabolites including homovanillic acid (HVA) and vanillylmandelic acid (VMA). The 
radiology services were involved and he diagnosed with metastatic adrenal neuroblastoma stage 4S. An 
echocardiography (ECHO) was performed and showed valvular pulmonary stenosis. He was referred to the oncology 
department, and made a good recovery following an intensive course of chemotherapy. 
Conclusion: This case is of particular interest because of the co-existence of congenital neuroblasoma and congenital 
heart disease is rare, our case provides further evidence for this association and to review the literature concerning this 
unusual but clinically significant relationship which might require further investigations and echocardiography might be 
required for all patients with congenital neuroblastoma. 
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Introduction 
The association of neuroblastoma and congenital 
heart disease might have clinical consequences and 
cardiac screening might be required for all patients 
diagnosed with neuroblastoma for further 
management [1, 2]. 
Case presentation 
A three-week-old male infant presented with 
abdominal distension and a history of failure to 
thrive. He was born at 38 weeks gestation to 
non-consanguineous parents, following an 
uneventful pregnancy. On examination, his head 
circumference, weight and length were in the 0.4
th
 
percentile.  Both heart rate and blood pressure 
were in the high normal range. His peripheral 
pulses were normal and his heart sounds were 
normal with a soft systolic ejection murmur on the 
left upper sternal edge, radiating to his back. He 
was noted to have marked abdominal distension 
and abdominal palpation indicated massive 
hepatomegaly and splenomegaly. There was no 
evidence of skin lesions.  Other systems were 
normal.  
Investigations  
A diagnosis of adrenal neuroblastoma, stage 4S, 
was made based on the following investigations: 
The laboratory results showed high levels of 
urinary catecholamines and their metabolites 
including homovanillic acid (HVA) and 
vanillylmandelic acid (VMA). Abdominal 
ultrasound (US) showed hepatomegaly with 
echogenic areas (Fig. 1) and a left suprarenal mass 
of 1.6 cm diameter. Computed tomography (CT) of 
the abdomen revealed hepatosplenomegaly and 
evidence of soft tissue encasing the coeliac axis and 
superior mesenteric artery (Fig. 2). CT of the head 
was normal. The meta-iodobenzylguanidine 
(MIBG) scan showed a focal increase in tracer 
activity uptake in the left adrenal gland, consistent 
with the site of tumour mass; uptake elsewhere was 
within physiological limits. Liver biopsy showed 
marked parenchymal destruction with nodules of 
necrotic hepatocytes; there was biliary reaction 
with neo-ductular proliferation and cholistasis. 
There was no evidence of N-myc amplification. 
Bone marrow trephine biopsy showed no evidence 
of metastatic neuroblastoma within the bone 
marrow.  
At 3 months of age he was referred to a 
paediatrician with expertise in cardiology. 
Echocardiography showed moderate valvular 
pulmonary stenosis with a maximum velocity of 
3.5m/s. There was no evidence of right ventricular 
hypertrophy and right heart dilatation.  
Treatment 
The child was referred to the oncology department 
in the tertiary centre and commenced an intensive 
course of chemotherapy. He responded well and 
made a good recovery following a long stay in the 
paediatric intensive care unit. Subsequent 
abdominal US showed that the left adrenal mass 
had disappeared. His liver had decreased in size, 
though a heterogenous echotexture persisted. 
Subsequent Echocardiography scans over the first 
year of life have remained unchanged. He remains 
under regular review as balloon dilatation of the 
pulmonary valve might be required in the future.  
 
 
 
 
 
 
 
 
 
 
 
Figure 1 Abdominal ultrasound: hepatomegaly with 
multiple echogenic areas. 
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Figure 2 CT of the abdomen: A- Hepatosplenomegaly with liver metastasis, B- Soft tissue encasing the 
coeliac axis and superior mesenteric artery. 
Discussion 
The association of neuroblastoma with 
congenital cardiac malformations is rare and to 
date, 67 cases of neuroblastoma associated with 
congenital heart disease have been reported [3]. 
The exact nature of this association is still 
uncertain.  
Neonatal tumours are rare and comprise 2% 
of all paediatric malignant tumours.  
The neonatal malignancies include 
neuroblastoma (47%), retinoblastoma (17%), 
soft tissue sarcoma (12%), central nervous 
system tumours (9%) and leukaemia (8%). 
Neuroblastoma is the most common type of 
neonatal tumour.  
Neonatal neuroblastoma originates from 
neural crest cells of the adrenal medulla or the 
sympathetic ganglia and can metastasize in 
utero. The majority of congenital neuroblastoma 
(34%) had metastatic disease (stage 4S) [4], it 
comprises as a small primary tumour and 
metastatic disease confined to the liver, skin, 
and bone marrow. The most common site of 
distant metastases is the foetal liver; other sites 
include the placenta, the retroperitoneal nodes, 
bone, skin, and the umbilical cord. Pulmonary 
and brain metastases are uncommon. Overall 
3-year survival of stage 4S disease is between 
71% and 86%, with significant decrements if 
any negative biological marker (no MYCN 
amplification) [5]. 
Developmental abnormalities of the cardiac 
neural crest have been implicated in a subset of 
congenital heart defects. A wide variety of 
congenital heart lesions have been associated 
with congenital neuroblastoma, from outflow 
anomalies (tetralogy of Fallot, transposition of 
the great arteries, double outlet right ventricle, 
common arterial trunk)to inflow lesions 
(tricuspid atresia, double inlet left ventricle) and 
aortic arch lesions (interrupted aortic arch, 
double aortic arch) [1, 2].   
The association of neuroblastoma with 
congenital cardiac malformations has been 
described and is multifactorial in origin. 
Different theories have been put forward to 
explain this relationship: 1) Abnormal neural 
crest development affecting both the cardiac and 
sympathetic nervous systems 2) 
hypoxia-induced changes; 3) the ‘2-hit’ theory 
of carcinogenesis; and 4) the role of genetic 
factors. 
1) Abnormal neural crest developmental 
affecting both systems 
Abnormal development or migration of neural 
crest cells has been explained as a mechanism 
that could contribute to the coexistence of 
congenital cardiovascular malformations and 
neuroblastoma [6, 7, 1].  
Neuroblastomas are derived from cells of the 
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neural crest. Neural crest cells play an important 
role in the septation of the outflow tract of the 
heart and in the formation of the conotruncal 
part of the ventricular septum. Changes within 
the cardiac neural crest have been implicated in 
a wide variety of congenital heart lesions, from 
inflow lesions to outflow anomalies and aortic 
arch lesions. Neural crest-derived congenital 
heart disease has been reported to be more 
frequent in neuroblastoma patients [2, 3]. 
2) Hypoxia-induced changes:  
Twenty three of the 67 cases (34%) had cyanotic 
cardiac anomalies. It has been suggested that 
cyanotic cardiovascular lesions and the resultant 
chronic hypoxia may stimulate the neural crest 
derived primitive adrenal medullary cells of the 
sympathetic nervous system to proliferate. This 
compensatory increase in cellular proliferation 
may eventually give rise to neoplasia [8]. 
3) The ‘two-hit’ theory of carcinogenesis: 
It has been proposed that a germ-line 
(pre-zygotic) mutational event of a tumour 
suppressor gene might lead to a congenital 
cardiac malformation (teratogenesis).  Loss of 
the second allele by a post-zygotic mutation 
may then result in formation of the 
neuroblastoma (carcinogenesis) [9]. 
4) Genetics factors 
The combination of congenital heart disease and 
neuroblastoma has been reported in some 
chromosomal anomalies, for example, 
translocation 3;10, 8p trisomy, or 22q11 deletion 
[10,11]. Several underlying genetic factors have 
been suggested in the aetiology of 
neuroblastoma, such as dominant inheritance 
with variable penetrance. Some cases may be 
related to the new mutations of major 
susceptibility genes controlling the neural crest 
development in the affected individual.  
Conclusion 
1. The exact nature of this association is still 
uncertain and further pathological and 
embryological studies remain necessary to 
define this relation. This association might 
have clinical consequences.  
2. If neuroblastoma patients have a higher risk 
of congenital heart disease (CHD), cardiac 
screening might be indicated for all 
neuroblastoma patients. Early detection of 
CHD could be important for the patient, in 
terms of choice of anti-cancer treatment and 
possible need for treatment of the CHD [3].  
3. Nevertheless, cardiac patients with 
cardiomyopathy and recurrent episodes of 
ventricular tachycardia and fibrillation had 
been linked to neuroblastoma mediated 
catecholamine release, and resolved on 
removal of a coexistent neuroblastoma [12, 
13], therefore; urine catecholamines 
screening might be useful in cardiac 
patients.  
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